Form 4 Filing for Arbutus Biopharma Corp

Roger Sawhney, a director at Arbutus Biopharma Corp, reported a disposition of 17,142 common shares on October 1, 2026. The shares were tendered to the Issuer pursuant to a tender offer, and the transaction was completed on the same date. The sale price was $5.00 per share, resulting in 13,683 shares remaining in Sawhney's ownership post-transaction. This filing, designated as a Form 4, indicates a change in beneficial ownership. The reporting owner is Roger Sawhney, and the issuer is Arbutus Biopharma Corp, trading under the symbol ABUS.